NCT00131638 2016-12-16A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck CancerAmgenPhase 3 Completed241 enrolled
NCT00434161 2015-03-30A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple MyelomaSwedish Orphan BiovitrumPhase 3 Completed281 enrolled 27 charts
NCT00109031 2014-09-15Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)Swedish Orphan BiovitrumPhase 3 Completed47 enrolled 19 charts